NAG-thiazoline

CAS No. 179030-22-9

NAG-thiazoline( GlcNAc-thiazoline )

Catalog No. M23803 CAS No. 179030-22-9

NAG-thiazoline is an O-GlcNAcase inhibitor with Ki value of 180 nM. It is active against V. campbellii with MIC value of 0.5 μM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 48 In Stock
5MG 45 In Stock
10MG 85 In Stock
25MG 180 In Stock
50MG 259 In Stock
100MG 420 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    NAG-thiazoline
  • Note
    Research use only, not for human use.
  • Brief Description
    NAG-thiazoline is an O-GlcNAcase inhibitor with Ki value of 180 nM. It is active against V. campbellii with MIC value of 0.5 μM.
  • Description
    NAG-thiazoline is an O-GlcNAcase inhibitor with Ki value of 180 nM. It is active against V. campbellii with MIC value of 0.5 μM.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    GlcNAc-thiazoline
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    O-GlcNAcase|VhGlcNAcase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    179030-22-9
  • Formula Weight
    219.26
  • Molecular Formula
    C8H13NO4S
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (456.08 mM)
  • SMILES
    CC(SC1OC(CO)C2O)=NC1C2O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.NAG‐thiazoline is a potent inhibitor of the Vibriocampbellii GH20 β‐N‐Acetylglucosaminidase[J]. FEBS Journal, 2020.
molnova catalog
related products
  • 2-Hydroxy-2-methylbu...

    2-Hydroxy-2-methylbutyric acid is an unusual metabolite found in the urine of patients with 2-hydroxyglutaric aciduria and maple syrup urine disease.

  • Sodium succinate

    Sodium succinate is the sodium salt form of succinate which is an important metabolite at the cross-road of several metabolic pathways and involved in the formation and elimination of reactive oxygen species.

  • Neuromedin S (rat)

    Potent, endogenous neuromedin U receptor agonist (EC50 values are 65 and 91 pM at NMU1 and NMU2 respectively). Induces phase shifts in the circadian rhythm of locomotor activity following i.c.v. administration. Potent endogenous anorexigenic peptide.